Tes Pharma S R Lis A Biotechnology Company Based In Corcianoitalyfounded In 2011 By Professor Roberto Pellicciarithe Nametescomes From The Etruscan Languagemeaninghealcurelove Which Reflects The Company S Mission To Provide Innovative Therapeutic Solutionstes Pharma Focuses On Biotechnological Research And Developmentparticularly In Oncologymetabolic Diseasesand Renal Diseasesthe Company Employs Expertise In Various Scientific Fields To Discover New Drug Candidatesincluding Orphan Nuclear Receptors Tes Pharma Has A Diverse Portfolio Of Drug Discovery Projectswith Notable Candidates Like Tes Onc 07 And Tes Aki 01Which Have Been Presented At Significant Industry Conferencesthe Company Collaborates With Other Pharmaceutical Firmsincluding A Renewed Partnership With Intercept Pharmaceuticalsto Enhance Its Drug Development Effortswith A Small Team Of Around 17 Employees And An Annual Revenue Of Approximately $6 Milliontes Pharma Is Committed To Advancing Innovative Therapies In The Biotechnology Sector
